Skip to main content
Equibles
VSTM logo

VSTM · Verastem, Inc.

Track VSTM — free Ask ALVIS about VSTM
$6.23 +0.15 (+2.47%) At close · Jul 28
Going-concern doubt — flagged May 7, 2026

Substantial doubt about the company's ability to continue as a going concern.

“In accordance with the applicable accounting standards, these conditions raise substantial doubt about the Company's ability to continue as a going concern for twelve months after the date the condensed consolidated financial statements are issued.”
View the 10-Q filed May 7, 2026
Market Cap
$534.27M
Shares
87.87M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.23 Open$6.08 Day$5.94–6.25 52W$3.43–11.25 Avg vol 30d2.9M Short int20.1M · 22.9% float · 6.8d Short vol62% Last earningsAug 6, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 7

Up next

Next earnings call
Aug 6, 2026 Scheduled · in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 7, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Weak Sentiment Bullish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 18.2 · elevated Equity put/call 0.71
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg −4%
      below
      Price vs 50-day avg +37%
      above
      RSI (14) 70
      neutral
      MACD trend Positive
      52-week position 36%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +65%
      trailing
      6-month return 0%
      trailing
      YTD return −19%
      this year
      Relative strength −8%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $5 › 200d $7 — 200d above 50d
      Institutional flow Accumulating
      20 of 156 funds reported for Jun 30 · net +72.9K sh shares · +8 new
      Insider flow Distributing
      Net -$4.7K over 90 days · 100% sells
      Short interest Falling
      22.88% of float · ▼ -16.7% MoM · 6.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      156 holders — near 3-yr high, broad support
      Squeeze score 83
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +209%
      Y/Y
      EPS growth +17%
      Y/Y
      Free cash flow $-137.5M
      Balance sheet $190.2M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 78%
      annualized · 1-yr
      Max drawdown −68%
      past year
      ATR 6.6%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 5 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −4% Neutral
      Price vs 50-day avg
      +37% Bullish
      RSI (14)
      70 Neutral
      MACD trend
      Positive Bullish
      52-week position
      36% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $5 › 200d $7 — 200d above 50d
      Institutional flow Accumulating
      20 of 156 funds reported for Jun 30 · net +72.9K sh shares · +8 new
      Insider flow Distributing
      Net -$4.7K over 90 days · 100% sells
      Short interest Falling
      22.88% of float · ▼ -16.7% MoM · 6.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      156 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $3 Now $6 · 36% 52-wk high $11
      vs 200-day avg -4% vs 50-day avg +37%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      VSTM
      Verastem, Inc.
      this stock
      		$534.27M -19.3% +285.2% — 22.9%
      ONC
      BeOne Medicines Ltd.
      		 $471.01B +7.3% +22179.2% 958.5 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $121.57B +8.2% +46.2% 28.4 2.0%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $69.95B -9.8% +20.8% 16.3 3.3%
      ARGX
      Argenx SE
      		 $54.57B +3.7% — — 2.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      162
      % held
      92.7%
      Reported
      20 of 156
      Top holder
      RTW INVESTMENTS, LP
      Held Float
      View
      Held by Funds
      Fund positions
      121
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      20.1M
      Days to cover
      6.8d
      Change
      -4.0M sh
      View
      Short Volume
      Short vol %
      62%
      As of
      Jul 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      81.3K
      Value
      $310.7K
      As of
      Jun 30, 2026
      View
      Off-Exchange
      Off-exchange %
      40.6%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$4.7K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $30.9M
      Net income (FY)
      $-209.5M
      EPS diluted
      $-3.02
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Jun 30, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $188.0K
      Shares
      31.9K
      Filed
      Jul 23, 2026
      View
      Exempt Offerings
      Offering
      $100.0M
      Filed
      Mar 6, 2020
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Aug 6, 2026
      Last call
      Jun 23, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      VSTM +8.4% +64.8% -0.3% +63.1% -19.3%
      SPY -1.0% 0.0% +7.4% -0.8% +8.6%
      vs SPY +9.3% +64.8% -7.8% +63.9% -27.9%
      Key facts CIK 1526119 CUSIP 92337C203 13F (30d) 19 filings 19 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)